AV

Adithi Vaish

Active Director Director DIN 08560469
DIN 08560469 First appointment Sep 2019 Primary industry Trading
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Sep 2019
Shareholding value •••• Premium profile

About Adithi Vaish

Data last updated:

Adithi Vaish is a Director at Adnis Pharmaceuticals Private Limited (since 2019). The company operates in Trading. Adnis Pharmaceuticals Private Limited reported revenue of ₹66.9 Lakh (FY 2024).

DIN 08560469
Primary Designation Director
Industry Trading
First Appointment 12 Sep 2019
Oldest Company Age 7 yrs
Largest company Adnis Pharmaceuticals Private Limited · ₹66.9 Lakh (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director12 Sep 20192019₹66.9 Lakh (FY 2024)Active

Board colleagues of Adithi Vaish

NameDINCompanyDesignation
Nishant Kumar08560468Adnis Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Adnis Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Adithi Vaish

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Adithi Vaish

Adithi Vaish currently holds 1 directorship: Adnis Pharmaceuticals Private Limited (Director, since 12 Sep 2019, revenue ₹66.9 Lakh (FY 2024)).

Adithi Vaish was first appointed on 12 Sep 2019 as Director at Adnis Pharmaceuticals Private Limited.

The current boards of Adithi Vaish's companies include Nishant Kumar (Adnis Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available